Clinical study of catheter balloon dilatation therapy for neurogenic cricopharyngeal achalasia

范文可,吴毅,路微波,田威,吴军发
DOI: https://doi.org/10.3969/j.issn.1001-1242.2011.05.005
2011-01-01
Abstract:Objective: To investigate the effects of catheter balloon dilatation therapy on treating patients with dysphagia caused by neurogenic cricopharyngeal achalasia. Method: Thirty-six patients of dysphagia caused by neurogenic cricopharyngeal achalasia were diagnosed through video fluoroscopic swallowing study (VFSS). The patients were divided into a treatment group and a control group randomly. The treatment group was treated with catheter balloon dilatation therapy and routine dysphagia rehabilitation training, while the control group was treated with routine dysphagia rehabilitation training only. The treatment end point was either the patient resuming an oral diet or after 6-week treatment (5 times treatments per week). All cases were evaluated by swallowing function and VFSS before anil after treatment. Result: After 6-week catheter balloon dilatation therapy, 13 of the 18 patients in treatment group regained the ability to take solid food and water orally, 15 of them could take pasty food, only 3 patients had no significant effect. Only 6 of the 18 patients in control group regained the ability to take solid food and water orally, 11 of them could take pasty food, 7 patients had no improvement. There was a significant difference between the two groups(P<0.05). After treatment, VFSS scores in both groups were significantly better than those before treatment (P<0.01). Compared the both groups after treatment, VFSS scores in the treatment group were significantly higher than those in the control group(P<0.05). Conclusion: Catheter balloon dilatation therapy is effective for neurogenic cricopharyngeal achalasia caused by stroke, traumatic brain injury and brain tumor.
What problem does this paper attempt to address?